Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Table of Contents

May 15, 2023; Volume 20,Issue 5
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

C

  1. Chai, Ruichao

    1. You have access
      Evolution-driven crosstalk between glioblastoma and the tumor microenvironment
      Lingxiang Wu, Ruichao Chai, Zihan Lin, Rongrong Wu, Diru Yao, Tao Jiang and Qianghu Wang
      Cancer Biology & Medicine May 2023, 20 (5) 319-324; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0771
  2. Cui, Xiaoteng

    1. You have access
      Identification of the E2F1-RAD51AP1 axis as a key factor in MGMT-methylated GBM TMZ resistance
      Junhu Zhou, Fei Tong, Jixing Zhao, Xiaoteng Cui, Yunfei Wang, Guangxiu Wang, Chunsheng Kang, Xiaomin Liu and Qixue Wang
      Cancer Biology & Medicine May 2023, 20 (5) 385-400; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0011
    2. You have access
      Expert opinion on translational research for advanced glioblastoma treatment
      Xiaoteng Cui, Yunfei Wang, Junhu Zhou, Qixue Wang and Chunsheng Kang
      Cancer Biology & Medicine May 2023, 20 (5) 344-352; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0012

F

  1. Fang, Chuan

    1. You have access
      Development of glioblastoma organoids and their applications in personalized therapy
      Can Xu, Xiaoye Yuan, Pengyu Hou, Ziru Li, Changsheng Wang, Chuan Fang and Yanli Tan
      Cancer Biology & Medicine May 2023, 20 (5) 353-368; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0061

H

  1. Hou, Pengyu

    1. You have access
      Development of glioblastoma organoids and their applications in personalized therapy
      Can Xu, Xiaoye Yuan, Pengyu Hou, Ziru Li, Changsheng Wang, Chuan Fang and Yanli Tan
      Cancer Biology & Medicine May 2023, 20 (5) 353-368; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0061

J

  1. Jiang, Tao

    1. You have access
      Evolution-driven crosstalk between glioblastoma and the tumor microenvironment
      Lingxiang Wu, Ruichao Chai, Zihan Lin, Rongrong Wu, Diru Yao, Tao Jiang and Qianghu Wang
      Cancer Biology & Medicine May 2023, 20 (5) 319-324; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0771

K

  1. Kang, Chunsheng

    1. You have access
      Identification of the E2F1-RAD51AP1 axis as a key factor in MGMT-methylated GBM TMZ resistance
      Junhu Zhou, Fei Tong, Jixing Zhao, Xiaoteng Cui, Yunfei Wang, Guangxiu Wang, Chunsheng Kang, Xiaomin Liu and Qixue Wang
      Cancer Biology & Medicine May 2023, 20 (5) 385-400; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0011
    2. You have access
      Expert opinion on translational research for advanced glioblastoma treatment
      Xiaoteng Cui, Yunfei Wang, Junhu Zhou, Qixue Wang and Chunsheng Kang
      Cancer Biology & Medicine May 2023, 20 (5) 344-352; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0012

L

  1. Li, Qiushi

    1. You have access
      Nanomedicine-based combination therapies for overcoming temozolomide resistance in glioblastomas
      Chun Wang, Qiushi Li, Jian Xiao and Yang Liu
      Cancer Biology & Medicine May 2023, 20 (5) 325-343; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0761
  2. Li, Ziru

    1. You have access
      Development of glioblastoma organoids and their applications in personalized therapy
      Can Xu, Xiaoye Yuan, Pengyu Hou, Ziru Li, Changsheng Wang, Chuan Fang and Yanli Tan
      Cancer Biology & Medicine May 2023, 20 (5) 353-368; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0061
  3. Lin, Zihan

    1. You have access
      Evolution-driven crosstalk between glioblastoma and the tumor microenvironment
      Lingxiang Wu, Ruichao Chai, Zihan Lin, Rongrong Wu, Diru Yao, Tao Jiang and Qianghu Wang
      Cancer Biology & Medicine May 2023, 20 (5) 319-324; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0771
  4. Liu, Xiaomin

    1. You have access
      Identification of the E2F1-RAD51AP1 axis as a key factor in MGMT-methylated GBM TMZ resistance
      Junhu Zhou, Fei Tong, Jixing Zhao, Xiaoteng Cui, Yunfei Wang, Guangxiu Wang, Chunsheng Kang, Xiaomin Liu and Qixue Wang
      Cancer Biology & Medicine May 2023, 20 (5) 385-400; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0011
  5. Liu, Yang

    1. You have access
      Nanomedicine-based combination therapies for overcoming temozolomide resistance in glioblastomas
      Chun Wang, Qiushi Li, Jian Xiao and Yang Liu
      Cancer Biology & Medicine May 2023, 20 (5) 325-343; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0761

P

  1. Peng, Wenjie

    1. You have access
      Recent progress in targeting the sialylated glycan-SIGLEC axis in cancer immunotherapy
      Yingyan Yu and Wenjie Peng
      Cancer Biology & Medicine May 2023, 20 (5) 369-384; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0046

T

  1. Tan, Yanli

    1. You have access
      Development of glioblastoma organoids and their applications in personalized therapy
      Can Xu, Xiaoye Yuan, Pengyu Hou, Ziru Li, Changsheng Wang, Chuan Fang and Yanli Tan
      Cancer Biology & Medicine May 2023, 20 (5) 353-368; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0061
  2. Tong, Fei

    1. You have access
      Identification of the E2F1-RAD51AP1 axis as a key factor in MGMT-methylated GBM TMZ resistance
      Junhu Zhou, Fei Tong, Jixing Zhao, Xiaoteng Cui, Yunfei Wang, Guangxiu Wang, Chunsheng Kang, Xiaomin Liu and Qixue Wang
      Cancer Biology & Medicine May 2023, 20 (5) 385-400; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0011

W

  1. Wang, Changsheng

    1. You have access
      Development of glioblastoma organoids and their applications in personalized therapy
      Can Xu, Xiaoye Yuan, Pengyu Hou, Ziru Li, Changsheng Wang, Chuan Fang and Yanli Tan
      Cancer Biology & Medicine May 2023, 20 (5) 353-368; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0061
  2. Wang, Chun

    1. You have access
      Nanomedicine-based combination therapies for overcoming temozolomide resistance in glioblastomas
      Chun Wang, Qiushi Li, Jian Xiao and Yang Liu
      Cancer Biology & Medicine May 2023, 20 (5) 325-343; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0761
  3. Wang, Guangxiu

    1. You have access
      Identification of the E2F1-RAD51AP1 axis as a key factor in MGMT-methylated GBM TMZ resistance
      Junhu Zhou, Fei Tong, Jixing Zhao, Xiaoteng Cui, Yunfei Wang, Guangxiu Wang, Chunsheng Kang, Xiaomin Liu and Qixue Wang
      Cancer Biology & Medicine May 2023, 20 (5) 385-400; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0011
  4. Wang, Qianghu

    1. You have access
      Evolution-driven crosstalk between glioblastoma and the tumor microenvironment
      Lingxiang Wu, Ruichao Chai, Zihan Lin, Rongrong Wu, Diru Yao, Tao Jiang and Qianghu Wang
      Cancer Biology & Medicine May 2023, 20 (5) 319-324; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0771
  5. Wang, Qixue

    1. You have access
      Identification of the E2F1-RAD51AP1 axis as a key factor in MGMT-methylated GBM TMZ resistance
      Junhu Zhou, Fei Tong, Jixing Zhao, Xiaoteng Cui, Yunfei Wang, Guangxiu Wang, Chunsheng Kang, Xiaomin Liu and Qixue Wang
      Cancer Biology & Medicine May 2023, 20 (5) 385-400; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0011
    2. You have access
      Expert opinion on translational research for advanced glioblastoma treatment
      Xiaoteng Cui, Yunfei Wang, Junhu Zhou, Qixue Wang and Chunsheng Kang
      Cancer Biology & Medicine May 2023, 20 (5) 344-352; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0012
  6. Wang, Yunfei

    1. You have access
      Identification of the E2F1-RAD51AP1 axis as a key factor in MGMT-methylated GBM TMZ resistance
      Junhu Zhou, Fei Tong, Jixing Zhao, Xiaoteng Cui, Yunfei Wang, Guangxiu Wang, Chunsheng Kang, Xiaomin Liu and Qixue Wang
      Cancer Biology & Medicine May 2023, 20 (5) 385-400; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0011
    2. You have access
      Expert opinion on translational research for advanced glioblastoma treatment
      Xiaoteng Cui, Yunfei Wang, Junhu Zhou, Qixue Wang and Chunsheng Kang
      Cancer Biology & Medicine May 2023, 20 (5) 344-352; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0012
  7. Wu, Lingxiang

    1. You have access
      Evolution-driven crosstalk between glioblastoma and the tumor microenvironment
      Lingxiang Wu, Ruichao Chai, Zihan Lin, Rongrong Wu, Diru Yao, Tao Jiang and Qianghu Wang
      Cancer Biology & Medicine May 2023, 20 (5) 319-324; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0771
  8. Wu, Rongrong

    1. You have access
      Evolution-driven crosstalk between glioblastoma and the tumor microenvironment
      Lingxiang Wu, Ruichao Chai, Zihan Lin, Rongrong Wu, Diru Yao, Tao Jiang and Qianghu Wang
      Cancer Biology & Medicine May 2023, 20 (5) 319-324; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0771

X

  1. Xiao, Jian

    1. You have access
      Nanomedicine-based combination therapies for overcoming temozolomide resistance in glioblastomas
      Chun Wang, Qiushi Li, Jian Xiao and Yang Liu
      Cancer Biology & Medicine May 2023, 20 (5) 325-343; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0761
  2. Xu, Can

    1. You have access
      Development of glioblastoma organoids and their applications in personalized therapy
      Can Xu, Xiaoye Yuan, Pengyu Hou, Ziru Li, Changsheng Wang, Chuan Fang and Yanli Tan
      Cancer Biology & Medicine May 2023, 20 (5) 353-368; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0061

Y

  1. Yao, Diru

    1. You have access
      Evolution-driven crosstalk between glioblastoma and the tumor microenvironment
      Lingxiang Wu, Ruichao Chai, Zihan Lin, Rongrong Wu, Diru Yao, Tao Jiang and Qianghu Wang
      Cancer Biology & Medicine May 2023, 20 (5) 319-324; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0771
  2. Yu, Yingyan

    1. You have access
      Recent progress in targeting the sialylated glycan-SIGLEC axis in cancer immunotherapy
      Yingyan Yu and Wenjie Peng
      Cancer Biology & Medicine May 2023, 20 (5) 369-384; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0046
  3. Yuan, Xiaoye

    1. You have access
      Development of glioblastoma organoids and their applications in personalized therapy
      Can Xu, Xiaoye Yuan, Pengyu Hou, Ziru Li, Changsheng Wang, Chuan Fang and Yanli Tan
      Cancer Biology & Medicine May 2023, 20 (5) 353-368; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0061

Z

  1. Zhao, Jixing

    1. You have access
      Identification of the E2F1-RAD51AP1 axis as a key factor in MGMT-methylated GBM TMZ resistance
      Junhu Zhou, Fei Tong, Jixing Zhao, Xiaoteng Cui, Yunfei Wang, Guangxiu Wang, Chunsheng Kang, Xiaomin Liu and Qixue Wang
      Cancer Biology & Medicine May 2023, 20 (5) 385-400; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0011
  2. Zhou, Junhu

    1. You have access
      Identification of the E2F1-RAD51AP1 axis as a key factor in MGMT-methylated GBM TMZ resistance
      Junhu Zhou, Fei Tong, Jixing Zhao, Xiaoteng Cui, Yunfei Wang, Guangxiu Wang, Chunsheng Kang, Xiaomin Liu and Qixue Wang
      Cancer Biology & Medicine May 2023, 20 (5) 385-400; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0011
    2. You have access
      Expert opinion on translational research for advanced glioblastoma treatment
      Xiaoteng Cui, Yunfei Wang, Junhu Zhou, Qixue Wang and Chunsheng Kang
      Cancer Biology & Medicine May 2023, 20 (5) 344-352; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0012
Back to top
PreviousNext

In this issue

Cancer Biology & Medicine: 20 (5)
Cancer Biology & Medicine
Vol. 20, Issue 5
15 May 2023
  • Table of Contents
  • Index by author

Submit

Sign up for alerts

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2023 Cancer Biology & Medicine

Powered by HighWire